Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

abagovomab MeSH Supplementary Concept Data 2025


MeSH Supplementary
abagovomab
Unique ID
C518318
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C518318
Entry Term(s)
ACA-125
ACA125
MEN-2234
Pharm Action
Antineoplastic Agents, Immunological
Registry Numbers
3YK0326U7X
Previous Indexing
*Antibodies, Anti-Idiotypic (2007-2009)
Heading Mapped to
*Antibodies, Monoclonal, Murine-Derived
Frequency
13
Note
used for treatment of recurrent ovarian cancer
Source
Ann Oncol 2006 Oct;17(10):1568-77
Date of Entry
2007/03/26
Revision Date
2019/10/30
abagovomab Preferred
ACA-125 Narrower
MEN-2234 Narrower
page delivered in 0.005s